Octopus leads £2m TrialReach round

Octopus led the deal and joined existing TrialReach backer Amadeus. The latter had previously provided TrialReach with $1.2m of early-stage funding at the end of 2011.

The company will use the fresh funds to develop its products further and launch new projects.

Company
Founded in 2009 and based in London, TrialReach offers an internet-based solution for matching patients with clinical trials. The company provides a search engine where participants can find clinical trials for their conditions, and subsequently screens applicants before referring them to researchers. The service is free of charge for candidates, while researchers pay for individuals they approve for trials.

People
Alliott Cole led the deal for Octopus. Pablo Graiver is CEO of TrialReach.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Technology
• Expansion
• United Kingdom
• Octopus Investments
• Amadeus Capital Partners Ltd